Quarters are matched automatically on the comparison year: pick once, both periods stay aligned.
| Line item | FY2027 (Q2) | FY2026 (Q2) |
|---|---|---|
| Revenue | $2.65B | $2.35B |
| COGS | — | — |
| Gross Profit | — | — |
| R&D | $747M | $660M |
| SG&A | $937M | $857M |
| Selling And Marketing Expense | $706M | $641M |
| General And Administrative Expense |
QuarterCharts · SEC EDGAR data · WDAY · Comparing FY2027 (Q2) vs FY2026 (Q2)
| $231M |
| $216M |
| D&A | $0 | $0 |
| Other OpEx | $652M | $583M |
| Restructuring Charges | — | $1M |
| Other OpEx (derived) | — | $582M |
| Operating Income | $313M | $248M |
| Interest Exp. | $28M | $29M |
| Interest Income | $40M | — |
| Other Non-Op | $0 | $0 |
| Other Non-Op (derived) | $2M | — |
| Non-Op Income | $42M | $85M |
| Pretax Income | $327M | $304M |
| Tax | $0 | $76M |
| Other (Below Tax) | $0 | $0 |
| Other Income (After Tax) | $0 | $0 |
| Tax Benefit | $305M | $0 |
| Net Income | $632M | $228M |
